Syschem (India) Ltd (531173) — FY26 Annual Report | 3 September 2026

Syschem (India) Limited's Annual Report 2025-26 details its full-year financial performance, strategic direction, and material risks. The company reported a 69.48% revenue increase to [amount context mismatch] crores and a significant net profit rise to [amount context mismatch] crores, driven by new plant operations. Key strategic moves include re-designating Ranjan Jain as Whole-Time Director and Suninder Veer Singh as Managing Director, with shareholder approval sought for their remuneration up to ₹7 lakhs/month. Material related party transactions with Pharmacare International (₹600 crores), Indosol Export (₹100 crores), and JB Khokhani & Co (₹100 crores) were approved for one year. The company also appointed Bansal Vijay & Associates as statutory auditors for 5 years and maintained a strong focus on risk management and corporate governance. No dividend was recommended. Material risks include foreign exchange volatility, raw material price fluctuations, and regulatory compliance. The report emphasizes expansion plans, ESG initiatives, and compliance with SEBI LODR regulations.